Luis Meillón

1.0k total citations
15 papers, 111 citations indexed

About

Luis Meillón is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Luis Meillón has authored 15 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Genetics and 5 papers in Rheumatology. Recurrent topics in Luis Meillón's work include Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). Luis Meillón is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). Luis Meillón collaborates with scholars based in Mexico, Brazil and Australia. Luis Meillón's co-authors include J Pizzuto, Vicente Baca, Jörge E. Cortes, Kátia Bórgia Barbosa Pagnano, Ricardo Pasqüini, Alicia Enrico, Timothy P. Hughes, Israel Bendit, Nelson Hamerschlak and Cármino Antônio De Souza and has published in prestigious journals such as Blood, Cancer and British Journal of Haematology.

In The Last Decade

Luis Meillón

13 papers receiving 107 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Meillón Mexico 5 93 55 48 15 13 15 111
Diamante Turri Italy 5 59 0.6× 49 0.9× 28 0.6× 15 1.0× 8 0.6× 8 97
Zonghong Shao China 8 117 1.3× 60 1.1× 20 0.4× 15 1.0× 18 1.4× 29 180
Craig A. Kovitz United States 4 87 0.9× 74 1.3× 44 0.9× 26 1.7× 4 0.3× 13 131
Kento Umino Japan 8 65 0.7× 32 0.6× 21 0.4× 31 2.1× 7 0.5× 23 148
Maria López‐Pavía Spain 9 108 1.2× 31 0.6× 8 0.2× 21 1.4× 12 0.9× 21 183
Giuseppe Auteri Italy 7 87 0.9× 63 1.1× 33 0.7× 9 0.6× 4 0.3× 22 143
Teresa Ferró Spain 6 48 0.5× 47 0.9× 15 0.3× 15 1.0× 18 1.4× 8 97
N. Pollicardo Italy 9 218 2.3× 108 2.0× 46 1.0× 28 1.9× 9 0.7× 15 237
Kimberly Yaung United States 3 89 1.0× 41 0.7× 37 0.8× 26 1.7× 18 1.4× 3 174

Countries citing papers authored by Luis Meillón

Since Specialization
Citations

This map shows the geographic impact of Luis Meillón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Meillón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Meillón more than expected).

Fields of papers citing papers by Luis Meillón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Meillón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Meillón. The network helps show where Luis Meillón may publish in the future.

Co-authorship network of co-authors of Luis Meillón

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Meillón. A scholar is included among the top collaborators of Luis Meillón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Meillón. Luis Meillón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Pavlovsky, Carolina, Kátia Bórgia Barbosa Pagnano, Michele Bianchini, et al.. (2021). Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel. Blood Advances. 5(23). 4855–4863. 13 indexed citations
2.
Hughes, Timothy P., Alaa Elhaddad, Jake Shortt, et al.. (2017). Nilotinib dose‐optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd. British Journal of Haematology. 179(2). 219–228. 16 indexed citations
3.
Hughes, Timothy P., Alaa Elhaddad, Abdulkadyrov Km, et al.. (2015). Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study. Blood. 126(23). 344–344. 3 indexed citations
4.
5.
Hughes, Timothy P., Alaa Elhaddad, Abdulkadyrov Km, et al.. (2014). Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis. Blood. 124(21). 4542–4542. 1 indexed citations
6.
Cesarman‐Maus, Gabriela, Luis Meillón, Patricia Volkow-Fernández, et al.. (2013). [Treatment of cancer and thrombosis: practical approach].. PubMed. 65(2). 174–82. 2 indexed citations
7.
8.
Cortes, Jörge E., Ricardo Pasqüini, Hagop M. Kantarjian, et al.. (2012). First-Line Treatment and Management of Chronic Myeloid Leukemia (CML) in Clinical Practice: Update of > 1800 Patients (Pts) in the WORLD CML Registry. Blood. 120(21). 3750–3750. 4 indexed citations
9.
10.
Cortes, Jörge E., Cármino Antônio De Souza, Israel Bendit, et al.. (2010). Current patient management of chronic myeloid leukemia in Latin America. Cancer. 116(21). 4991–5000. 20 indexed citations
11.
Pasqüini, Ricardo, Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2010). A Worldwide Observational Registry Collecting Longitudinal Data on Management of Chronic Myeloid Leukemia Patients (The WORLD CML Registry) – 2nd Annual Interim Analysis. Blood. 116(21). 2292–2292. 2 indexed citations
12.
13.
Baca, Vicente, et al.. (2002). Diagnosis of lupus anticoagulant in the lupus anticoagulant‐hypoprothrombinemia syndrome: Report of two cases and review of the literature. American Journal of Hematology. 71(3). 200–207. 36 indexed citations
14.
Perea, Francisco J., et al.. (1999). The Hb Tarrant [α126(H9)Asp→Asn] Mutation is Localized in the α2-Globin Gene. Hemoglobin. 23(3). 295–297.
15.
Meillón, Luis, et al.. (1996). Tromboembolia pulmonar en autopsias en un período de 10 años. 34(1). 7–11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diamante Turri Breakdown of academic impact, for papers by Zonghong Shao Breakdown of academic impact, for papers by Craig A. Kovitz Breakdown of academic impact, for papers by Kento Umino Breakdown of academic impact, for papers by Maria López‐Pavía Breakdown of academic impact, for papers by Giuseppe Auteri Breakdown of academic impact, for papers by Teresa Ferró Breakdown of academic impact, for papers by N. Pollicardo Breakdown of academic impact, for papers by Kimberly Yaung
Rankless by CCL
2026